Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김승현 | - |
dc.date.accessioned | 2018-04-19T05:32:41Z | - |
dc.date.available | 2018-04-19T05:32:41Z | - |
dc.date.issued | 2012-01 | - |
dc.identifier.citation | Special Issue: Stress and neurological disease, Experimental Neurology, January 2012, 233(1), p.72-480 | en_US |
dc.identifier.issn | 0014-4886 | - |
dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S0014488611004250 | - |
dc.identifier.uri | https://repository.hanyang.ac.kr/handle/20.500.11754/69356 | - |
dc.description.abstract | Amyotrophic lateral sclerosis (ALS) is caused by motor neuron death. The relationship between the prognosis of ALS patients and the function of their bone marrow mesenchymal stromal cells (BM-MSCs) is unclear. We designed this study to assess the correlation between the progression rate of the ALS Functional Rating Scale-revised version (ΔFS), which is reported to predict prognosis, and the pluripotency and trophic factor secreting capacity of ALS patients' BM-MSCs. We evaluated ΔFS in 23 ALS patients and isolated BM-MSCs from those patients and five healthy people. Levels of Nanog, Oct-4, and Nestin mRNA were examined to evaluate pluripotency, and levels of BDNF, ECGF1, bFGF-2, HGF, IGF-1, PGF, TGF-1β, SDF-1α, GDNF, VEGF, and ANG mRNA were examined to assess trophic factor secreting capacity. In addition, we measured the protein levels of Nanog, Oct-4, Nestin, SDF-1α, ANG, bFGF-2, VEGF, IGF-1, GDNF, and BDNF. mRNA levels of Nanog, Oct-4, ECGF1, bFGF-2, HGF, IGF-1, PGF, TGF-1β, SDF-1α, GDNF, VEGF, and ANG were negatively correlations with ΔFS. However, those of Nestin and BDNF were not significantly correlated with ΔFS. Similarly, Nanog, Oct-4, SDF-1α, ANG, bFGF-2, VEGF, IGF-1, and GDNF protein levels had a significant negative correlation with ΔFS. Results indicate that the pluripotency and trophic factor secreting capacity of the BM-MSCs of ALS patients are reduced in proportion to a poorer prognosis. We therefore suggest that healthy allogeneic BM-MSCs might be a better option for cell therapy in ALS patients. | en_US |
dc.description.sponsorship | This study was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A101712). | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Science B.V., Amsterdam | en_US |
dc.subject | Amyotrophic lateral sclerosis | en_US |
dc.subject | Prognostic factors | en_US |
dc.subject | Neurotrophic factors | en_US |
dc.subject | Mesenchymal stromal cells | en_US |
dc.title | The functional deficiency of bone marrow mesenchymal stromal cells in ALS patients is proportional to disease progression rate | en_US |
dc.type | Article | en_US |
dc.relation.volume | 233 | - |
dc.identifier.doi | 10.1016/j.expneurol.2011.11.021 | - |
dc.relation.page | 472-480 | - |
dc.relation.journal | EXPERIMENTAL NEUROLOGY | - |
dc.contributor.googleauthor | Koh, S. H. | - |
dc.contributor.googleauthor | Baik, W. | - |
dc.contributor.googleauthor | Noh, M. Y. | - |
dc.contributor.googleauthor | Cho, G. W. | - |
dc.contributor.googleauthor | Kim, H. Y. | - |
dc.contributor.googleauthor | Kim, K. S. | - |
dc.contributor.googleauthor | Kim, S. H. | - |
dc.relation.code | 2012203142 | - |
dc.sector.campus | S | - |
dc.sector.daehak | COLLEGE OF MEDICINE[S] | - |
dc.sector.department | DEPARTMENT OF MEDICINE | - |
dc.identifier.pid | kimsh1 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.